Purchase Articles
Showing 81–96 of 157 resultsSorted by latest
-
A Socio-Psychological Perspective on Flattening the COVID-19 Curve.
Read Article -
Patented Medicines Costs of Private Insurers: PMPRB Implications.
Read Article -
Fewer new drug approvals in Canada: early indication of unintended consequences from new PMPRB regs?
Read Article -
New Patented Medicine Regulations in Canada: Updated Case Study. (EN/FR)
Read Article -
Nouvelle réglementation sur les médicaments brevetés au Canada: Étude de cas mise à jour.
Read Article -
New drug submissions in the United States and Canada 2014-2019: trends and policy implications.
Read Article -
The costs of Immunoglobulin treatment in hospital and in the home in Quebec
Read Article -
New pathways for U.S. importation threaten Canadian prescription drug supply
Read Article -
Preventive care of the future? Economic analysis of cardiovascular risk management.
Read Article -
Coverage of new medicines in Federal-Provincial public drug plans in Canada 2009-2018
Read Article -
Coverage of new medicines in private versus public drug plans in Canada 2009-2018
Read Article -
Potential impact of U.S. demand on the Canadian supply of 46 prescription drugs.
Read Article -
Clinical Duty to Recontact in Genetic Testing: Insights from the Safety-Related Duty to Recall
Read Article -
Patented drug prices and clinical trials in 31 OECD countries 2017: implications for Canada’s PMPRB.
Read Article -
HTA and public coverage of new mental health drugs in Quebec and Canada.
Read Article -
Medical resources and spending across provincial healthcare systems in Canada.
Read Article